4//SEC Filing
Yarranton Geoffrey Thomas 4
Accession 0001181431-13-024865
CIK 0001293310other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 8:40 PM ET
Size
5.2 KB
Accession
0001181431-13-024865
Insider Transaction Report
Form 4
Yarranton Geoffrey Thomas
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2013-04-30+75,000→ 75,000 totalExercise: $6.00Exp: 2023-04-30→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option shares will vest and become exercisable ratably over 36 months of continuous service after May 1, 2013.
Documents
Issuer
KALOBIOS PHARMACEUTICALS INC
CIK 0001293310
Entity typeother
Related Parties
1- filerCIK 0001555737
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 8:40 PM ET
- Size
- 5.2 KB